Presentation is loading. Please wait.

Presentation is loading. Please wait.

L-Arginine Clinical Trial Results of Study 18% increase in HDL 18% increase in HDL 40% decrease in triglycerides 40% decrease in triglycerides 8% glucose.

Similar presentations


Presentation on theme: "L-Arginine Clinical Trial Results of Study 18% increase in HDL 18% increase in HDL 40% decrease in triglycerides 40% decrease in triglycerides 8% glucose."— Presentation transcript:

1

2 L-Arginine Clinical Trial Results of Study 18% increase in HDL 18% increase in HDL 40% decrease in triglycerides 40% decrease in triglycerides 8% glucose reduction 8% glucose reduction 25% decrease in C- Reactive proteins 25% decrease in C- Reactive proteins 11% reduction in serum creatinine levels 11% reduction in serum creatinine levels 35% increase in magnesium levels 35% increase in magnesium levels Vitamin D3 levels increased by 183% Vitamin D3 levels increased by 183% Systolic Blood Pressure decreased by 13% Systolic Blood Pressure decreased by 13% Diastolic Blood Pressure decreased by 17% Diastolic Blood Pressure decreased by 17% Peripheral blood flow to the feet increased by 16% Peripheral blood flow to the feet increased by 16%

3 Dr. Siva Arunasalam ProArgi-9+ Active Study

4 ProArgi-9+ Active HDHI Study 9 Healthy Subjects + Dan Austin 9 Healthy Subjects + Dan Austin Ages: 22-54 + d60an Ages: 22-54 + d60an

5 Hypothesis: If L-Arginine increases muscle blood flow, then there will be less lactic acid accumulation. Thus increasing endurance & muscle recovery. ProArgi-9+ Active HDHI Study

6 Measure lactic acid levels during vigorous exercise Measure lactic acid levels during vigorous exercise Lactic acid accumulates when body goes into oxygen debt Lactic acid accumulates when body goes into oxygen debt More vigorous the exercise the longer the duration of exercise, higher the lactic acid accumulation More vigorous the exercise the longer the duration of exercise, higher the lactic acid accumulation Lactic Acid causes muscle fatigue Lactic Acid causes muscle fatigue Lactic acid accumulation decreases muscle performance Lactic acid accumulation decreases muscle performance ProArgi-9+ Active HDHI Study

7 ProArgi-9+ Active Formulation By blocking oxidation of LDL cholesterol; counters major source of inflammation – precedes atherosclerosis By blocking oxidation of LDL cholesterol; counters major source of inflammation – precedes atherosclerosis Multiple studies performed with 100-200mg. with benefits including lowering BP by improving endothelial health Multiple studies performed with 100-200mg. with benefits including lowering BP by improving endothelial health Ingredients of PA9+Active have more than 200mg. per serving of Quercetin Ingredients of PA9+Active have more than 200mg. per serving of Quercetin Protection: Anti oxidant against factors such as oxidative stress, radiation, DNA damage & toxins Protection: Anti oxidant against factors such as oxidative stress, radiation, DNA damage & toxins Quercetin: Broad Spectrum Protection

8 ProArgi-9+ Active Results SubjectControlProArgi-9+ Active 11823 22936 34046 42025 5911 69 72832 81417 95664 103943 Endurance in min. 15% increase with ProArgi9+ Active


Download ppt "L-Arginine Clinical Trial Results of Study 18% increase in HDL 18% increase in HDL 40% decrease in triglycerides 40% decrease in triglycerides 8% glucose."

Similar presentations


Ads by Google